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SPARe (secreted protein acidic and rich in cysteine) 
is an extracellular protein associated with tissues 
exhibiting high rates of cell proliferation and matrix 
remodeling. The current work shows that the human 
melanOlna cell lines IIB-MEL-LES, IIB-MEL-IAN, 
and Im-MEL-] and different human metastatic mel-
anomas expressed high levels of SPARe mRNA and 
protein. By western blot analysis we detected a single 
secreted 42-kDa band in human diploid fibroblasts-
conditioned medium and a 45-to 40-kDa doublet in 
the three melanoma cell lines and all the metastatic 
melanomas tested. Part of the melanoma samples and 
cell lines showed an additional doublet of 36-34 kDa. 
SPARe mRNA was expressed by the three established 
cell lines, 14 metastatic melanoma samples, and tu-
mors raised in nude mice, and no spliced variants 
S PAR.C (also termed BM 40, 43 kDa. and osteonectin) is a secreted glycoprotein associated with cell-matrix in-teractions during remodeling, morpbogenesis, migra-tion, and proliferation. SPARC expression is develop-mentally regulated, and the predicted translation 
product ITom all SPARC cDNAs studied to date sbow a high 
degree of conservation (Lane and Sage, 1994). Although the precise 
role of this protein remai.ns to be established, SPARC, as with 
ten3scin, thrombospondin, and proteoglycans, acts as a COllnter-
adhesive protein that can disrupt focal adhesions of certain cells 
(Sage and Bornstein, 1991). Sage and colleagues h ave demon-
stra ted that SPARC binds to the B cbain of platelet-derived growth 
f.'lctor (H .. aines el ai, 1992), antagonizes the effect of basic fibroblast 
growth factor 011 endothelial cell migration (Hasselaar and Sage, 
1992) , stimulates the synthesis of PAI-l (Hasselaar e/ ai, 1991), 
decreases fibronectin and thrombospondu, expression byendothe-
lial cells (Lane ef ai, 1992), and possesses a Cu2 + -binding domain 
(Lane ef ai, 1994) , suggestulg a role for this protein in angiogenesis . 
SPARC was found to be overexpressed Ul different malignant 
tissues (Porter ef ai, 1995) . We and others bave demonstrated that 
SPARC expression is associated with the neoplastic progression of 
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Abbreviation: rSPARC. human recombinant SPARC. 
were found. The heterogeneous pattern of SPAR.e 
secreted by human melanoma cells is the result Of 
post-translational glycosylation and a specific extra, 
cellular leupeptin-inhibitable cleavage. Unlike hu, 
man fibroblasts, melanoma cells did not overexpress 
SPARe on addition ofTGF-fJ. ImmunohistochellliCa! 
analysis showed that SPARe was strongly expressed 
in 100% of primary Dlelanomas (7 of7) and metastatic 
melanomas (29 of 29), Dloderately expressed in IllOst 
of the positive dysplastic nevi (13 of 14), and only 
weakly expressed in nevocellular nevi (4 of 25). Nor, 
mal melanocytes did not express SPARe. The data 
suggest that the expression of SPARe is associated 
with the neoplastic progression ofhUIllan melanoIlla. 
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human breast (Bellahcene and Castrollovo, J 995; Podhajcer ef ai, 
1996) and colon CaJl cer (Porte ef aI, 1995) . In this report, we 
demonstrate that SPARC is overexpressed in human primary and 
m etastatic melanoma and in the preneoplastic lesions, dysplastic 
nevi, compared with benign nevocellular nevi and normal melano_ 
cytes, whjcb did not express SPARC. These data indicate that 
SPARC expression corre lates with neoplastic progression ofhllman 
melanoma. 
MATERIALS AND METHODS 
Cell Lines and Cell Cultures The lIB-M EL-J. lIB-MEL-LES, and 
lIB-MEL- IAN human melanoma ell Jines were established from metastatic 
melanomas in our laboratory (Podh:ticer pI ai, 1995). Human fetal lung 
fibroblasts HFL-I (ATCC, CCL 153) and IIB-Fl, a mesothelioma ceU line 
cstabUshed in our laboratory, were grown in Dulbeccl)'S modified Eagle's 
mcdium, 10'V" fetal bovine serum , and antibiotics. The human breast C311Cer 
cell line MCF-7 was grown in Dulbccco's modified Eagle'S mcdium:F12 
(I: 1) supplemented with 2 mM glutamine and 10 !J.g insulin per 1111. 10% 
fetal bovine SCrUITI, and antibiotic~ . Cultures were 111ailltained at 37°C in a 
5% CO2 humidified incub;,lQr. 
Expression of Recombinant SPARC and Preparation of Rabbit 
Antiserum A fulJ-lenglh cDNA for human SPA RC l!xtending frolll 
nucleotides (- ) 55 to (+ ) '1704 was ll1utagcnizcd ill "ifm to engineer an del 
ATG start codoll-containing site upstream of Ala II:! of the coding sequence 
and subcloncd into the expression vector pET -3 b as described (Podhajcer 'I 
ai, 1996). BL-21 cells transformed with pET -3b plasmid or with pET -3bl 
SPARC plasmid were grown and induced by I 111M isopropyl-{3-D-
thiogalactopyranoside, and the incubation was continued at 28°C for 3 h. 
Bacterial pellets were lysed and sonicated. Ce ll Iysates were centrifuged at 
100,000 X g for I h, and tbe supernatant was used for furtber purification 
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of recombin3nt SPAR.C. T h.e 100 ,000 X g supernatan t was C ncentrated hy 
adding ammonium sulfa te to 80'Y., saturation. After centrifugation. the pellet 
was resuspended in lysis buffer containing (, M urea and laaded on a 
diethylami.naethyl-Sephacel column (Pharmac ia, Uppsala, Sweden), and th e 
protein was eluted with a discontinuous NaCI gradient. R ecombinant 
SPARC eluted at 200 mM NaCI was dia lyzed agai nst phosphate-b uffered 
saline (PBS) containing gradually decreasing concentrations of urea until it 
was c ompletely removed. This SlI mple was used to raise a rabbit anti se rum 
according to standard pracedures (Harl.ow and Lane, 1(88). 
Protein Extraction and Western Blot Analysis Ta abtain se rum-free 
cell-conditioned medium, ce ll s were grown to nca r confluence. washed 
twice with PBS, and kept in se rum-free medium . After 24 h. the medi ull1 
was callected, centrifuged far 10 min at 1,500 rpm to remove' debris. 
precipitated with sa lid ammanium sulfate for I h . and cen tritllged at 
10,000 X g for 2 h . The precipitate was disso l ved il\ [JUS in the presence of 
protease inhibitors (phenyl l1Iethyl sulfo nyl fluaride and ethylene dialllinl' 
tetraacetic acid, I mM final concentratio n) and dialyzed against the ~ame 
buffer. 1 iaJyzed samples were divided and kept at - 70°C un til usc. For 
protein extractian. ce ll s were washed twice with PBS and lysed with I (j mM 
Tris(hydroxYl11ethyl)aminoll1ethane-HCI bulfer. pH H.n. containing 0.15 M 
NaCl, 1 % NJ>-40. and protease illhibita rs. AFter centrifugatia n at IO.!Hll) X 
g for 10 min at 4° . the supernatanr was used for ilTll11l1llohlotting . HUIll<ln 
melanoma sanlp lcs were cut into srnall pieces. frozen in li quid nitrogen. 
pulverized, and resuspended in 10 mM Tris(hydroxYl11ethyl)al11ill a ll'leth-
ane-HCl buJfer, pl-l 7.4. contajlJing U.S ITIM I)TT and protease inhibito r •. 
The Iysates were homogelli zed with a Pol yrro n (lanke &. Kllnkel KG 
IKA-WERK. Staufcn im Breisga u, GermallY) alld centrifuged al4 °C for 10 
min at '1,000 X S. T he 1.000 X g supernatant was further ccnrrifuged at 
100,000 X <~ for 2 h to o btain the cytoso li c fraction. After washing. the 
1000 X g pellet was resuspended in 50 111M Tris(hydroxYl11ethyl)al11illa-
medlane-I-ICI buller. pl-l B.O . CO lltaining 1')1" NP-40, ISO 111M NoC I. 5 111M 
KCI, 5 mM MgCI2 • and protease inhibi tors alld analyzed by immlllloblot-
ring a s described be low. Prote in samples were separated by redllced 
SDS-PAGE and transferred onto nitroce llulose lll embr'lJIcs. Presta ined 
molecular weight IIlflrkers were ,,,cd (cr2-microglobulin . J3-ga lactosidase, 
fructose 6-phosphate kinase. pyruvate kinase. tlll",' rase. lactic dehydroge-
nase, and triase phosphate isome,·ase. Sigma C hemica l Co ., St. LOllis. MO). 
After blocking wich dried skillllll ed milk in PBS. melllbrall es were incubated 
overnight at 4°C with the rabbit antisera raised against hUllIan rSPAR.C. 
After washing with 0.05% Twcen-20 in PBS. d, e membralles were filrther 
incubated for 2 h at roam tCllIperature with alkaline phosphatase-labeled 
goat anti-rabb it IgG (lackson Iomnuno R.cse:lrch Labs. West Grove. PAl · 
Bands were detected using nitrobluc tctrazoliul1\ chla ride and 5-hromo-4-
chloro-3-indaylphosphace fo llowing manufacturers' instructiom (GJBCO-
BRL, Gaithersburg, MD) . 
Tunicanlycil1 Treatment Nearly cOllfluellt IIB- M EL-LES edt- were 
wash e d twice with PBS "lid incubated with 'CflllIl frec-l'lle I;II10m'1 l1l ed illlll . 
After 5 b , this medium was discarded and replaced WiLh fres b m edium in the 
presence or absence of 4 p.g tUll lea ll1ycin per Ill!. After overnight incubatjon 
the m e dium was recovered and can centra ted with ammoniul1l slil/;ite. alld 
10 -15 ILg of protei II were analyzed by western blat. 
Enzytnatic Treatments for Carbohyd.rate Removal Sct'UIl1 frcc-
conditioned m ediull1 obtained Froll1 1I13- MEL-LES cells wa .. cOll cenlrmed 
with ammoniulll sulfate as descrihed . T ltirty nticrogra l1ls of cotal protein 
were treated either with elldo II (endo-i3-N-acery lgluco,a l11illidase H. 
Sigma C hemica l Co.) . PNGasc F (peptide: N-glycosidase F. Uio la[,s. 
Beverly, MA) or l1ellral1linid,, ~e (Bio la[, ) . EnzYlIla tic digestions with endo 
Hand PNGas(' F , el'e perforlll ed under della turing canditio ns. .01111'01 
samples without' enzymc were incubated ill the sallle hulfer 0(' sampil-s 
containing a glycosidase. 
Treatment with endo H (S ILl of 1.0 unit pCI' ,nl) was carried Ollt in 6() JJ.I 
of 0.05 M sodiulll citrate bllrrer. I'll 5.3. The reaction lIlL"t ure wa, 
incubated for 16 h at 37"C. Enzylllatil' digestiolls with PNGase F (3 lInil , ill 
a final v olume o f 6() ILl) were c"lTi cd ont in 0.05 M sl)diul11 pho<phatc. 1'14 
7.5, containin g 1% NP-4 0. fo Jl owing the manuf;octlfl'cr 's lnstrucl'ions. 
Trea tlTlcnt with nc urilrninidasc was caJ'ried out in 0. 15 M SQoiUllJ ilcet:Hl' 
buKer. pH 5.0, u,ing 10 tnU a('cnzyme al37°C for 16 h . TIll' reactians were 
stopped by the additio n o f loading bulte r. con wining SJ)S and J3-merca p-
coethanol. aJ1d hea ting. 1\ , a contro l fill' ' ndo H alld PNGa,e F 'I('ti,·it)'. we 
used RNase B. As a contra l for ncu"llIillid",e activity. we used 2' -(4 
metbylumbelli feryl)-c,-D-N-al'ctyl-ncuramil1ic ac id (4 MU-NANA) . 
RNA Extraction and Northern Blot Analysis Tota l RNA was ex-
tracted fra1'l1 human mc1"nomas or melanomas raised ill nude mice as 
described (ChOlllczynsky and Sacclti. 19H7). electrophoresed on I 'V. agarose 
gels in the presence of forma ldehyde. alld blo tted onco nylon lIlelllbr;llIes 
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(H ybond N. Arncrshall1 . Arlington Height's. IL) . After ultraviolct cmss-
linkillg, the membranes wcr~ hybridized avernight with " P-Iabcled ran-
dom-prin1('d eDNA probes (10" cpm per ml) i1l til<! pn"ence of 50% 
fo rrnamide al 42°C and washed as described . To detect PAR.C mRNA 
expressian. R.NA membranes were probed with a I .O-kb hurnan , PAR.C 
cDNA probe extending fromn1lcleoLides (+ ) 110 to ( + ) 1150 (Podhajcer er 
nl , 1996). I'tNA integriry and amounts were checked by membrane staining 
with me thylene blue and also by hybridiZ<llion with a cUNA corresponding 
to the lI biquitousl)' eXl'ressed gene 36B4 (Basset el nl, 1990). which codes 
fo r a ribosol11al phosphoprotein (Laborda. 1991). 
For scudies involving the effect of growth factors. nearly eanAuclit cdl> 
were rinsed with PBS and kept in medium without serum. After 24 h. cells 
were washed with PBS and incnbated in .lerum- free medium supplemcnted 
with 5 ng recombinant transfonning growth factor-{3 (TGF- J3) per III I 
(kindly provided by Dr. Santa Coloma. Buenos Aires). 5 Ilg EGF per mi. or 
1(\ ng phorbol \ 2 myristate 13-acetate per ml (Sigma Chemical Co, San 
Diego, CAl . At the indicated ti mes. ce ll s were washed twice with PB. and 
resuspended in guanidine isoth),ocianatc hull-er for RNA extraction . 
Immunostaining Techniques Paraffin-embedded risslle blocks were 
used far dL'1ection af SPARC by imlllunahistochemistry. The 5 JJ.I1l thi ck 
sli ces were Illowlted on polylysinc-caated slides . Endogenous peroxidase 
\v<lS c lilll imtted with 2')1" 1-1 ,0 2 in methanol. Melaniu pigments were 
eLiminated as previously described (Lulla, 19(0) . After blocking with 10% 
goat l10flnal scru rn for 15 ll1in at r001n tcnlpcraturc. slides \.vere.' incubated 
overnight at 4°C with th,' antiserum raised against I' PA R C (I :750 dilution 
in 1>13 ) or non immune rabhit serum fo llowed by thl' biotinylated gaat 
anti-·rabbit serulll . An avidin-biotin-pcroxidase complex was used following 
l1l<lllUfaClurcr's instruction ;;; (Vcctasta in . Vector Labora(oric~. Burling-alne. 
CAl and the rcaction waS developed \~ith (l.(12% dialllinobcnzidinc and 
H 20 2 · 
R ESULTS 
SPARC Is Present in Human Melanoma Cell Lines and 
Humall Metastatic Melanomas T h e specitic antiserum raised 
again t pm-ified human recombinant SPARC detected a 42-kDa 
band secreted by HFL- I ce lls (Fig tA) that corresponded to the 
expected ~ ize of glycosyla ted SPARC (Sage rr ill, 1989) . All the 
three human melanoma cell lines and IID-F! cells secreted a major 
reac tive band of 45-40 kDa (Fig lA) . [n addition, SPARC 
antisel'um recognized ,I second band 01'35- 34 kDa in IIB-MEL-LE 
and llD- M EL-IAN cell s (Fig lA) . When Ie,s protein was loaded. 
the b ands were vis ualized as doublets (sec Fig 2A) . Similar 
experiments were perfotll1ed with the soluble fraction of tissue 
extracts obtained fi'om six different human metastatic melaJlomas. 
Figure IB shows that SPARC antiserum reacted with different 
SPARC species with e lectropho retic 1l10bility similar to that of 
those secreted by the cell lines. In addition . t\vo of the . ix samples 
studied sho w e d an additio n a l douhlet of 36-34 kDa (Fig lB) . 
The Heterogeneous Pattern ofSPARC Expression Is Due to 
Glycosylatioll and Specific Cleavage by Melanoma Cells 
T he in cub3tioll of ITB-M EL-L . ce ll s with runicamycill gives rise 
to secre ted lower m o lecular mass specie. of 40.37.33. and 31 kDa 
(Fig 2A). suggesting that aii the species were glycosylated. PARC 
~ pecics with the hi g h er l110lecubr mas' after tlll1icam),cin treatment 
comigrated with rSPARC . A similar decn:ase in the molecular mas' 
of SPArtC spccies was a lso ohtain cd w h.:n liD-MEl -LES-condi-
tioned medium was treated with PNCase F (Fig 2B) . PARe 
~ecretcd b r melan o m a ("e ll s appeared to bc I'et'r<lctory to leavage hy 
en d o Hand nC'lll';llninidase. because we fo und no diifercll("c in the 
electrophoretic mobility of ,' I'A R C ~pe('h:s afte r treatmcnt (Fig 
2B). T hese results sll gges l that those SPARe specics with lower 
m o lecu la r nwsses Were products of proteolytic c leavage . This was 
specific for melanoma cells. heca llse it was never detecte d in 
llFL- I - or lH3-FI-conditioncd m edia . We a lso found that !cuper-
tin. a se rine/ cyste ine protea'e inhibitor. was able to inhihit PAR 
cleavage (Fig 2C). 
To test the poss ihility that a lternative sp liced varia nts may a l 0 
givL' ri se to the ditJ-crellt spccies fi)lllld in western blocs. we analyzed 
SPARC mRNA expression by northent blots. Figure 3 sho " s that 
the threc established human melanoma cell lin es and tumors raiser! 
in nude mice CO n s(;tuci"e]y expressed hig h levels of SPAR . 
mRNA . 111 addition. 14 human m etastatic l11elanom:ls sh owed 
212 L£DDA ET ; IL 
A 
B 
u 
a: 
<{ 
Cl. 
'{! 
...J 
u.. 
I 
(/J 
W 
...J 
...J 
w 
~ 
~ 
Metastatic Melanomas 
2 3 4 5 
• 38 
• 33.5 
6 
• 38 
• 33.5 
Figure 1. SPARe protein is present in human melalloma. (A) Each 
lane was loaded with 30 J.l.g of total protein obtained from serulll-free 
conditioned medium «ee Malr/inls "lid Methods for cell lines description). 
T he mobility of rSPARC is also shown. (8) Each lane was loaded with 100 
J.l.g of total protein obtained frOIll tumor extnlcrs. The sites or origin of the 
metastases were: lymph node. samples I. 2. 4. and 5; viseer"l, s"lTlp le 3; 
derma. sample 6. Proteins were reso lved by 10% SOS-PAGE gel under 
reduced conditions. ImlTlunoblotting W~IS performed as described in Mate-
rials alld Merl",r/s using" rabbit antisennn raised against rSPAR.C. The 
migration of bctic dehydrngenase and triosephosphate isolller"sc is indi-
cated. 
varying levels of expression of the 2.2-kb band corresponding to 
the major SPARe transcript. Some of them also expressed a tracc 
amount of thc minor 3.0-kb transcript that corrcsponds to a poly A 
variant that codified for the same molccular mass protein (Fig 4 , 
Howc 1'1 nl, 1990; Podl1ajccr 1'1 al. 1996). No ev idence for spliced 
variants was observcd in the samples tested. 
Immunohistochemical Detectiol1 of SPARC SPARe was 
detected iml1lunolustochemicaUy in all the metastatic melanomas 
(29/29) and primary melanomas (seven of seven) tested. SPARe 
was predominantly located in the cytoplasm of malignant ce Us (Fig 
Sa-c) . Sta ining was also observed in endothelia l cells (Fig Sc) and 
fibroblasts (not shown). Lymphocytes did not stain (Fig Sb) . 
SPARe immunostaining was also moderately to strongly detected 
in most of the dysplasric nevi analyzed (13 of 14) (Fig St!) . In 
contrast, 84%, (four of 25) of nevocellular nevi did not stain, 
whereas staining was present in sweat and sebaceous glands and in 
somc cases in cpideml is (not shown). Normal follicular and epi-
dermal melanocytes did not stain . 
SPARC mRNA Expression Is Not Regulated by TGF-fJ in 
Human Melanoma Cell Lines Confirming previous reports 
(Lankat-Buttgereit CI ai, 1991; Wrana ef al. 1991; R.eed et ai , 1994), 
we observed a S.2-fold increase in SPARC InRNA expression in 
HFL-l cells following TGF-/3 addition (Fig 6) . SimjJ ar studies 
perfomlcd in all the thrce human melanoma cell lines demonstrated 
that TGF-/3 addition h,ld no cffect on the steady-state levels of 
SPARe mRNA (Fig 6) . By rchybridizing the blot corresponding to 
IIB-MEL-LES cells. we observed that TGF-/3 upreguJated 92-kDa 
mRNA levels. demonstrating that melanoma cells were able to 
respond to TGF-/3 addition (not show n). No effect o n SPARe 
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Figure 2. DeglycosyJation and specific cleavage of human SP~ 
by melanoma ceU~ . Serum-free ce ll-cOllditiolled mediulll was obtained; 
described in (\fnted"ls 11/111 ~J('II",ds . (AJ I .m/l·s 1.2. n/lll4 cOlltain 12 J.l.g ~;. 
tota l. protein; Inll f 3 connllns 0.25 J.l.g of rS.I'AltC. Condi tiOllcd mcdiunl 
obt~nned from IfB-MEL-LE~ ce ll s treated. wItho ut (/m l(' I) or with ((,1/1" 1) 
tunical1lycin ; Imll' 4. condillo ll.ed III cd," tr<~111 1-If'L- 1 <:ells. (8) Each lall~ 
cont~i~s 30 J.l.g ?f total protell1 obl'nned Irol1l 111:3- MEL-LE se"llll\-fre~ 
condltloned mcd,unl. Lmll' 1. ulltreated cell<: Imre 2. trcated with llCllral11.;". 
id.se; Inlle 3. illcubat.cd ill r~euralllinid.ase buller: Inllt' 01. treated with PNGas" 
F; lalll' 5, Incubated III PNGasc F buCkr; Inlll' 6. trealed wilh c'ndo H ' lalle 
incubated in elldo H b .,dfcr. (C) ~a{"h lane ~' olllaill< 30 J.I.!!, of II I3-MEL-LES 
,erull1-fr~e ce Il -conditioned IllCdltlll1 : obLlllled III lhe pre<cnce of different 
protease ",Jub,tors al the followln!!, IlIl al CO llcelltrallom. Lnll L' I. no inhib, 
itor; IntH' 2. cthylenedia11lilletctraacctic "cin. (I 1l1:v') ; 111 111' 3. le ll pcptine (0.01 
111M); 11I1It' 4. pepst"tllle A (0.00 I mM) . 1 he migration of fumarase. laCtic 
dehydrogellase, and tri()sepl~o'.!'ha.tc i<t:,~", ra,e is indiclled . (AJ and (C). 
Protellls were resolved by lO X. ::;n::;- i'A(.J: gl'l under dena turin!!, condition,. 
(8) Proteins were resolwd by all SI >S-PAGE !I- I H'X. gradicm lInd"r 
denatw;ng conditions. 
mR.NA regul ation by melanoma cell s was observed 011 the addition 
of cpidenTla l growth facto r or phorbol esters (not shown). 
DIS USS ION 
We have sh own that all the prim"r), and metastatic samples We 
tcsted expres ed high levels ofS PARC I'roleil1. whereas most of the 
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Figure 3. SPARC ",RNA is expressed in buman melanoma cell 
lines and I11clalloma tUJll0rs raised in nude mice . Total R.NA (12 J.l.g) 
corresponding to hUTn3n IItchlJ101 l Ia ce ll lillt'S or lO lllunan lnclanonlJ, 
tumo rs raised ill nude micc were loadl·d ill e"cit lone . After hybridizing \\~th 
SPAR.C probt:. membranes "".'re rehybridized with .~6 134 probe for COlU-
parable loan ing. Autoradiography wa, for 72 h ar - 7(l°C. 
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Figure 4. SPARe mRNA is expressed in human IUetastatic mcla-
nontas. Total rtNA (S lAg) correspondillg to diRcrL'lIt IIl"rastatic melallo-
mas was loaded in e"eh lalle. The sites of origill of the IIH' taslases were the 
following: sample I, IUllg: samples 3. 4, 6. 8, 10. 12. alld 13, 1)'l11ph nodes: 
samples 2, 5, 7. ,,"d II , del'll": samples 9 alld 14, viscera. AUloradiography 
was tor 72 h at - 70GC. Methylen" hlue 'tain ing of nylon Ill"mbranes shows 
RNA integrity and comparahle IO;ldi ng. 
dysplastic nevi showed moderate levels of expressioll. A low 
percentage of benign nevoceUular ncvi showed only wcak exprcs-
sion, and normal melanocytes did not express SPA RC. Thcse 
results suggest that SPARC is impli ca ted in the neoplastic progres-
sion of human melanoma. 
SPARC expression was associatcd with tissues exhibiting high 
rates of cell proliferation and matrix remodeling (Sage and Bom-
stein.. 1991; Lane and Sage. 19(4). SPARC was shown to upregu-
late the expression of fibroblast- derived l11etalloproteinases (Trel11-
ble ct nl. 1(93), to anchor plasminogen to coll agcn matrices (Kelm 
et nl, 1994). and to modulate laminin and fibronectin secretion in 
norma l and malignanr cclls (Kamihagi el aI, 19(4). suggcsting a key 
role for this protein in matrix remodeling. More recently, SPARC 
was found to be overexpressed in fibrohlasts surroundi ng breast 
(podbajcer el nl. 19<)6) and colon callcer cells (Porte cl Il/, 19(5) . It 
was suggested that signa ls originating IToll1 tUl1lor cc ll s may regu-
late SPARC levels in neighboring fibroblaslS. leading to the 
hypothesis that SPAR . may playa role in cancer progression . 
Unlike breast and colo n cancer ce ll s. m cla noma ce ll s by thelllsc ives 
expressed high le vels of SPARC. T hese le\lels were not upregu-
late d by a known stimu la tor of SPARC expression ill fibrob lasts. 
TGF-{3. These data indi cate that the high cOllstitutive expressioll of 
Figure 5. Immunohistochemical detection of SPARe in human 
melanoma and dysplanic nevi. Paraftin-l'I'llbecldccl lis,,'e secl.ions wcre 
stained by the imll1un opcroxidllse method as d,,<cribcd in iI'/"IC";"/S (lIId 
Melhods. (n,b,r) Mctast"ti c melanomas : (d) dysplasric nevus. (tI) Intcn <" 
stain.ing is observed in cpi thcloid- li ke melanoilla ce lls ("1'/'(""): (II) highn 
magnification of (I section of p"",,/ n sho'\ving one tll1110r l..~ cJl with il1tC'llse 
intracytoplasmic <taining and ncg~l ti ve IYlllphocytes (»: (r) intense ,raining 
of melanoma ce lls (0) and endotheli al ce lls (» is ohserved : (d) b'lsa l 
d)'splastic I1lchll1 oc)'tes , howing positive staining (» . Posi tive endothelial 
cells a re also seen . 'scnft' bars, (I,r. 12.5 fJ.1ll: b. 4.2 fJ.1ll: d. 5 IAn). 
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Control· time (h) TGF ·B1 • time (h) 
3 7 15 24 3 7 15 24 
HFL·1 -SPARe 
-3664 
-- SPARe 
IIB·MEL·LES 
-36B4 
-- SPARe 
IIB·MEL·J 
-- 3664 
-SPARe 
IIB·MEL·IAN 
-36B4 
Figure 6. Th" IlillNA levels of SPARe in human melanoma ceUs 
arc not regulated by TGF-{3. Ncarly cOllfl uent 1l1ciallOll1a ell, or HFL-I 
cells were washed as desn;bed iJl Malc"in/s alii/ J\1rr/r,.ds alld incuhlltcd in the 
pre" ' lIel' or ahsence of 5 IIg TGF-{3 per ml for the indicated times , atrer 
which total RNA was extracted as descrilwd. Tot,,1 RNA (Ill lAg) was 
loaded in each lalle . The bini was first hyhridi1cd with a " P-laheled SPAR 
cDNA prohl' alld th"n n:prnhed with th" 36134 prolw. Autoradiography wa< 
tor 72 h 'lIld 24 h. reSI1l'l'tivciY.;lt - 70g C . Th,' band< \\'ere scalllled with all 
UL TROSCAN XL densitometer (Pharmacia. SWl' dl'n) . 
SPAR may confer on melanoma cells the capaciry to modulale by 
themselves the matrix remodeling necessary for tumnr progression. 
The question whether SPAR . produced by the malignant cells 
thcmse lves, as in human melanoma, or by surrounding; fibroblasts. 
as in breast and colon cancer. pl"ys " ~itllilar role in tumor 
progression is being cnlTenti investigated. 
We have also shown that SPAR. undergoes post-translarional 
glycosylation and l'xtracellulal' cleavagc that appears to bl' specific 
of IllcianOllla ce ll s. Til,' higher lllo iccu lal' weight SPARe species 
delectcd in melanoma cclls showed an apparelll molecu lar wcight 
that exceeds that· of HFL- t fihrobbsis by approximately :!OOO-
JO()O. It is likely that this differe nce corresponded to an increased 
level of post-tralHlational glycosylation in melanoma cells. because 
after deglycosylation, the major melanoma SPAR spccies de-
tected in conditioned media had an electrophoretic mobility iclen-
tica l to that ofrSPAKC. Although SPARC glycosylation was fonnd 
to he unnecessary for the inhibition of spreading and binding to 
'ndothclial cells (Yost ('/ III. 19(4). Kelll1 and Mann (t 9( 1) have 
recently shown that bonc SPAR " ha"ing a high man nose-type 
oligosaccharide struCtUl'l', but nOt platelet SPAKC, with complex 
type oligosaccharide side chains, was capable of binding to inter-
stitia l collagen. S01lle discrepancy has appeared in the titerature. 
beGlllse SPAKC secreted by bovinc endothelial cells and fibroblasts 
contains complex carbohyclrate moietics and shows affinilY for 
collagens ( age ('( nl. 1989). Deglycosylatl'd SPAR ,however, was 
indistingui shable /i'om the native molecule in its capacity to bind 
collagen IV , lllld only the delcrion of the l1'-he lical clornain abol-
ished this capacit), (Pottgiesser CI nl. 19(4) . The susccptibililY of 
melanoma SPARC to cleavage by PNGase F and not hy endo H 
and neuraminidase slll,1:gests that melanoma SPAR possesses a 
complex type oligos:lCclwridc Slructure ditfe,;ng from that obser\'ed 
in platelet SPARC, because the latter was susceptible to neurarnin-
idasl' treatment. This difference Illa y confer on melanoma SPAR 
a capacity for specific binding to matricellu lar components different 
fi'om those reported previousl), for other species. 
In addition to the differcnces ill po,t-translational glycosylation, 
thc specitic cleavage of SPAR by melanoma cells may also ha\'e 
important implicatiollS in cnncer progrl's.ion. Pcptidcs correspond-
ing to differellt dOlllains of the protein h""e demomtrated specific 
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acnvltJes on cell proliferation, shape regulation. and binding to 
collagen that were sometimes masked in the whole protein (Lane 
and Sage, 1994). SPARe was shown to inhibit endothelial cell 
proliferation; however, peptides corresponding to cationic se-
qucnces of domain II stinlU lated endothelial ceJJ and fibroblast 
proliferation (Funk and Sage, 1993). Domain 11 contains the 
cationic sequence KKGHK, which was implicated in promoting cell 
growth and angiogenesis (Lane ef ai, 1994); domains III and IV 
were responsible for SPARe binding to collagen IV (Lane and 
Sage, 1990). More recently, it was demonstrated that SPARe 
cleavage by chymotrypsin produced a 30-kDa fragment and re-
leased the entire domain IV (Maurer el ai, 1992). SPARe was also 
specifically cleaved by another serine protease, elastase, in the 
acidic domain I at two closely adjacent sites, producing fragments 
of 32 and 34 kDa and releasing part of domain I. The nature of the 
fragments obtained after SPARe cleavage by melanoma ceJJs is 
unclear. This cleavage appears to be mediated by serine /cysteine 
proteases present in the conditioned media of these melanoma cell 
lines (Podhajcer et ai, 1995) . It is conceivable, however, that 
SPARe cleavage and the release of specific protein domains may 
greatly alter the functional role of SPARe and hence melanoma 
cell interaction with the matrix. Because SPARe may also modu-
late angiogenesis (Irucla-Arispe el ai, 1991; Reed el ai, 1993), it is 
tempting to suggest that SPARC expression by melanoma cells may 
have a key role in melanoma progression. 
Tltis ",ork II'OS slIpjJoriet/ ill pon by grmllsfrolll the Nmiolla l COIII/cil ofSciwt!lic allli 
Tpdlll,,'o.~ i( Research, CON/CET. alii/ F'llldoei')11 Sales . L.B .• J.M .• alld O.L.P. 
are mel/lbers ofCONICET. M.F.L. is aIel/ow ofCONICET (/lid S.A. is afellolll 
of Fllm/ari')/I Sales. I-li e arkllol/lled,~(' MO/lica DOIIOldsOll, No/iolla l COlll lllissioll 'if 
Atolllic E/lergy,J"r pn",idillg li S lI'i,II tile ""dr /IIice alld Lilia/In A lollsofor ')'pill,~ ,IIe 
maHllscript, 
REFEREN CES 
Ba;s" t P.lkUoeqjP. Wolf e. Stollj. Hutin p. Lima eher jM. Podhajeer OL. Chenard 
MP. Ilia Me. Chambon P: A novel mcralloprotein3se gene specificalJy expressed 
in stromal cells of bre~ ~t carcinoma'\. Nfltllre 348:699-704 . 1990 
Bellahcenc A. Castronovo V: In creased c;\:p ression of osreonectin and osteopOllcin . 
(WO bon e matrix proteins. in human breast cancer. Am) Parl",1 146:95-100. J 995 
Chomczynski p. Sacchi N : Single step method of RNA isoiarioll by acid gUi1nidin ium 
thiocyanate-phenol-chloroform extraction. Aual Bi{)rhefll 162: 156-159, 1987 
Funk SE. Sage EH: Differemial effect< of SPARC and cationic SPARC peptides o n 
DNA s),nthesis by endothelial cells and fibrobla stS. ) Cdl Pltysiol 154:53-63 . 1993 
J-Iarlow E, Lane 0: Iml11l1llization~. In: Atlfihociil's: A LnbortHol1' I\/rlllllal . Cold Spring 
Harbor Laboratory. Cold Sl'rin!l; Harbor. NY . 19R8. cll"pter 5. I'P S3-'L3S 
Ha sselaar 1'. LoskutoffDj. S,l\vdcy M. Sage EH: SPARC indu ce< the exprcssion of type 
I plasminogen acriv.ltor inhibitor in cultu red bovine aortic endothelial ce lls.) Bioi 
CI,,.,,, 266:1 3 178-IJI S4. \9 9 \ 
Hasselaar P. Sage EH: SPAR.C antagonizes the c trcC[ of basic fibrobla ~ t growth factor 
on the migr:ltion of bovine aortic endotheHal cells. J Cdl Hive/H'/II 49:272-283. 
1992 
llowe ce. Karh R . M:lI1 cianti ML, Hcrl yn M. Mue lle r S, C ri 'l lofilln V; E.xpression and 
'i tru (.' [urc of hum .. " SPARe rrftl1sclipt''I: SPARe mRNA is expressed by human 
cells involved in extracellular n1<ttrix pruduCTion and some nf these cells 'ihow an 
unusual expressioll piHlcrII . Exp Cdl R.(·s I HH; I R5- 1 C) 1. 1990 
Irucla-ATis-J.H..' ML. Hilsse lar P. Sa ge EH: Diffe rential expression o f cX lracellul ar protein 
j" corrcl:llcd with angiog:cllc~i ... ;/1 I,ilro. Ltlh 11fI't!s/ 6-1: .174 -I R6. 1991 
K ~HlIjl);lgi K. Katayam.l M . O uchi R. Karo I : OMconCCLiJl /S PARC rcgllla[e~ eXlfrlccl-
THE JOURNAL OF INVEST IGAT IVE DERMATOLOGy 
lular secretion nlfeli of fibrol1cctin and l::trninul extrncellu l"r matrix prOteill ~ . 
.8i(l("<111 Biofl"Ys /{eJ Co",,,,,,,, 200:423-428. 1994 
Keirn I\J , Mann K~ : The coll,agen hjndill ~ spccifi~ity orbonc :1nd platelet osteonectin 
is related to differen ces ]n glyco'ylatton . ) BIOI Cirri" 226:%32-9639. 199 1. 
Kdm R.J, ~word NA~ Orfc.o 1. ~ Mann KG: Oste~ l~cCt:n in m.lub; remOdeling . A 
plasmrnogen-o"eo nectrn-coiJagen co mplex.) BIOI CIr.,,, 269:30 14 7-30153. 1994 
Laborda J: 36B4 cDNA used as an estradiol-independent mltNA control is the cDNA 
for human ;'IcldlC nbosomal phosphopfQte 11l PO , Nucleic Acids Res 19:3998 199 
Lane TF. Iruela-Ari, pe ML. Johnson RS. Sage EH: SPARC is a 'Ource of c~ 1 
binding peptide, that stimulate angiogencsi<.) Cdl BioI I 25: C)29-943. 199~per, 
Lane TE Irucl a~A.rispe .ML. S~ge El-I : Reg~lation of g~nc e"pressiol'l by SPARe 
dUring angiogenesIs //I II/1m : cilallgc"i III flbroncHIII. lhrOtnhospondin_l . 
plasminogen activator inhibitor- I.) Wal Cltl'll' 267: 16736-1 6745. 1992 and 
L.me TF. Sage EH: Fun e,tiOJ'tt l lIulppi ,ng of SPA~tC: pcptiuc s from two distinct sites 
modulate cell adheSIon.) Cell BIOI III :31)60-3076. 1990 
Lane TF. Sage EH: The bio logy of SPARC. a protein that modulates cell-marn, 
inter:wjons . FASEI3) 8: 163-173. 1994 ~ 
Lankat-Bultgercit B. Kul()zik M. l-Iunzc1",alln N. Krieg T : Cytokincs alter rnRNA. 
steady state levels ror basem enl membrane prute ins in human "ikin fibroblasts. J 
D ermotol Sri 2:300-307. 1991 
LUlla LG: Rou~ill~ s~a~njl1g proccdl.lrc s; II'Iclani,n pig lllCJ:fS . In: Lun:1 LG (cd.). J\/nullal 
of Hisrolo)!lc Sta"'HI,,! MI'Iht)ds f!i fhe Arnll'tl l 'nrrcs III .Hlrll/f' {~r Pnl1tolll~}I. The Blakisto 
Division . McGraw-Hili Book Company. New York. 196f1. p 42 n 
Maurer p. Mayer U. Bruch ~. j eno p. Mann K. Landwehr 11.. . Engel .I . Timpi H .. 
High-affinity and low-Olfhniry CalclUl11 binding Ollld litahi lity of the l11ultid()Jnai~ 
extracellular 30-kDa hasc ll1 ~ l1[ ll1el1lbrane glycoprotein (BM-40/S PAR.C/os_ 
teol1ecol1). Ellr} Bior""", 205 :233-240 . 1992 
Podhaj ccr OL. Baver L. Bravo AI. Lcdda MF. Kaidyal1l a C. C"lb I. Guerr" L, Capon\' 
F. Mordoh J: Exprcs~~OJl Of. ca th epSin D 111 primary and I11cr.a:Hatlc hllm~ 
melanoma and dysplastiC ncv l. J 1I111t.'sf J nll/dlill 104 :340-344, I <J95 
Podhaj cer OL. Wolfe. Lcfd>vt< O. SegainjP. ROllyer N. Stoll I. Rio MC. C harnbon 
P. Baliset P: COmpilriJO Ve expression of the SPARe ~md "ltrolilclysin-3 genes in 
mammary tumors. Tilt' lJl'cmf 5: 13-20. 19lJ6 
Porre H. Chastr. I. Prevot S. Nord li nger 13. Empercur S. 13asset p. Ch.mbo n P 
Gcspach C I-I : N eoplastic progression of 111.1111:11"1 colnrcelal ea ll eer is associa ted 
with overexprcssion orthc strol'llelysin-3 tlild BM- 4IlJSPAftC genes. lilt) CallC,.,. 
64:70-75. 1995 
Porter PL. Sage EH. Lane Tf. Funk SH. (jown AM : DiStrihution ofSPARC in normal 
and neoplastic tissue . ) J-lisllJCbelll C ylorllctl! 43 :79 1-tHHl, 1995 
Pottgiesscr J. ~aurcr p. Maycr U. Ni,eilt R ... Malin K. Timpl R. Krieg T. Engel j : 
Changes 111 cal Cium :lI1d co ll <1gcl1 " billdlng (~a\lsed by 11l11tation ~ in th~ EF hand 
and other domains of ex tr:l ce llular matrix pnHcin BM-40 (SPARe. ()s[eon~ctin) . 
) Mill BioI 238:5(,3-574. 1994 
R.aines EW . Lane TF. Irue la- Ari'pc ML. Ro<s R . Sa~e EH: The extracellular 
glycoprotein SPARe inte racts with plate let-de rived grow th factor (PDGF)-AB 
and -BB and inhihit'i th e binding ofPDGF ('0 its rece ptor. Pror Na tl Acari ci USA 
89: l281-121\5. 1992 
R..eed MJ . Poulakkaincn PA , Lane TF. Dickerson D. Bornstein P. S4Ige EH: Expression 
of SPAR.C ;md thro mbospol1din- 1 ill wOllnd rcpair: iml1luI101ocaJization and i" 
si'" hybridizatioll . ) HisleJr/1I'I1i C)'lflrJltI li 4\: 1467- 14 77. 1993 
Reed Mj. Vemon R.B. Abra"j13 . Sage Ell : TGF-f3 1 induce, the expression oft)'pc I 
coll ilgen and SPARe. and enhallces COli trac tion uf ('o llagt'fI gels, hy tibroblasts 
frolll yo un g and aged dOl1on , J (.'(,11 Ph}lsjo/ ISH: 1 (,9- 179. 1994 
Sage EH. Bornstein P; Extracellular protcinc; that modulate cell-III:IlT'L,,< inte ractions. 
) BioI Clterrr 266:1483 1-14H34. 1991 
Sage El-I. Vernon lU3 . Funk SE. Evcrit EA. An~c110 j : SPA It .. a ,ecrctcd protein 
;1 ssociatcd with cellular prolifcf:1tion, iJ1hihil ~ cell ~ pre ;I(Jing ill lIilm flnd exhibit, 
Ca" dependent binding to the cXlraccllul.r ,n:ltriX. J Cdl BinI 109:341-356. 
1989 . 
Tremble PM , lane TF. Sage BI J. Werb Z: S PA R...C. a ~ct:l'Cl:cd protein associntcd with 
morphogenesis and ti~"lHt. fcmodding. indtH.' l'$ cxprcv";lo n of rnetal1npro[cillascs 
in fi,hroblast~ through (J nove l l'xtr<tccllul:1r Illarrix-dq.Jcndl'IH patll\.v;IY· J Cell Billl 
12 1: 14 33-1444.1993 
Wrana JL. Overall eM. Sode 1< : Reg ulatiol) of dH.~ cx pr(.' <;sioll of a sccrch!d addk 
protein rich in cysteil1c, (SPAKe) ill human f1bl'obl:l(,ts by tnmsformillg: growth 
factor f3. EliI') Hillel ... ", 1 'l 7:5 19 -52R. I ')') I 
Yo" jC. Bell A. Scale R . Sage Ell : Purift cativ n of biologicall y activc SPAR.C 
{!xpresscd in Sarc/ufr(llIIyres ({·"i'I,j.~ jn('. AI",.II U;Clr /u'UI H;oph)l.f 3 1·1:5U-63. 1994 
